Highly rated in
Highly rated in
Check Dr. Justin M. Rineer's experience treating your condition:
About Dr. Justin M. Rineer

Justin Rineer is a Radiation Oncologist in Orlando, Florida. Rineer has been practicing medicine for over 19 years and is highly rated in 25 conditions, according to our data. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, EGFR Positive Lung Cancer, and Prostatectomy. He is licensed to treat patients in Florida. Rineer is currently accepting new patients.

His clinical research consists of co-authoring 44 peer reviewed articles and participating in 5 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Justin M. Rineer it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Justin M. Rineer accepts the following insurance:

  •  Ambetter
  •  Molina Healthcare
  •  Cigna
  •  Sunshine Health
  •  AvMed

Call to see if your plan is accepted.
1400 S Orange Ave, Orlando, FL 32806
Other Locations
9900 W Colonial Dr, Ocoee, FL 34761
Background & Education
Graduate Institution
State University Of New York Downstate Medical Center, 2004
Radiation Oncology
Radiology in FL
Hospital Affiliations
Orlando Health Orlando Regional Medical Center
Orlando Health - Health Central Hospital
Orlando Health South Lake Hospital
Orlando Health South Seminole Hospital
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Safety Evaluations of Nivolumab (Anti-PD-1) Added To Chemotherapy (CRT) Platforms In Patients With Intermediate And High-Risk Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-small Cell Lung Cancer (NSCLC)
View 4 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors